ICTERICIA COLESTASICA ASOCIADA A HEPATITIS A AGUDA
Resumen
Texto completo:
PDFReferencias
R. S. Koff, “Hepatitis A,” The Lancet.1988, 351 (9116) :1643–1648.
Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev 2001; 14: 38-58.
Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine 1993;10 (1):S:18-20.
Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18 (Suppl 1):S 71–4
Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis HM, editors. Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991. p. 14±20
R. S. Koff, “Clinical manifestations and diagnosis of hepatitis A virus infection,” Vaccine. 1992, 10 (1), pp. S 15–S17.
Robert T. Lapp and Fedja Rochling, “Acute Cholestatic Hepatitis A Virus Infection Presenting with Hemolytic Anemia and Renal Failure: A Case Report,” Case Reports in Hepatology. 2013, vol. 2013, Article ID 438375, 4 pages.
Gökçe, S., Çenesiz, F., & Özalp, A. E. (2014). Steroid treatment of protracted cholestatic hepatitis A in a child with β-thalassemia. The Turkish journal of Gastroenterology: the official journal of Turkish Society of Gastroenterology.2014, 25, 278-279.
Torbenson M. S., Biopsy interpretation of the liver. Wolter’s kluwer health. 2015. P 62.
Xiao S., Oshima K., Liver Pathology. Demos Medical. 2015. Pag 5
Yoon EL, Yim HJ, Kim SY, et al. Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases. The Korean Journal of Hepatology. 2010;16 (3):329-333
Pullukçu, H., Kahraman, H., Yamazhan, T. et al. Use of steroids for prolonged cholestasis secondary to acute hepatitis A. J Microbiol Infect Dis. 2014; 4: 162–164.
Enlaces refback
- No hay ningún enlace refback.
Revista Médica Carriónica. Todos los Derechos reservados por el Cuerpo Médico del Hospital Nacional Dos de Mayo, Lima, Perú.